Global Pentavalent Antimonials Market Insights, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 116

Report ID: 19872

Pentavalent Antimonials, also called pentavalent antimony compounds, are used to treat patients with leishmaniasis, but they have collateral effects and, in some cases, low cure rate. The compounds currently available for clinical use are: sodium stibogluconate and meglumine antimoniate. Pentavalent antimonials can only be given by injection.
The global Pentavalent Antimonials market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pentavalent Antimonials market based on company, product type, end user and key regions.

This report studies the global market size of Pentavalent Antimonials in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pentavalent Antimonials in these regions.
This research report categorizes the global Pentavalent Antimonials market by top players/brands, region, type and end user. This report also studies the global Pentavalent Antimonials market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct

Pentavalent Antimonials market size by Type
Sodium Stibogluconate
Meglumine Antimoniate
Pentavalent Antimonials market size by Applications
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pentavalent Antimonials market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pentavalent Antimonials market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pentavalent Antimonials companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pentavalent Antimonials submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pentavalent Antimonials are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (g). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pentavalent Antimonials market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Pentavalent Antimonials Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pentavalent Antimonials Market Size Growth Rate by Type
1.4.2 Sodium Stibogluconate
1.4.3 Meglumine Antimoniate
1.5 Market by Application
1.5.1 Global Pentavalent Antimonials Market Size Growth Rate by Application
1.5.2 Hospitals Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pentavalent Antimonials Market Size
2.1.1 Global Pentavalent Antimonials Revenue 2014-2025
2.1.2 Global Pentavalent Antimonials Sales 2014-2025
2.2 Pentavalent Antimonials Growth Rate by Regions
2.2.1 Global Pentavalent Antimonials Sales by Regions
2.2.2 Global Pentavalent Antimonials Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pentavalent Antimonials Sales by Manufacturers
3.1.1 Pentavalent Antimonials Sales by Manufacturers
3.1.2 Pentavalent Antimonials Sales Market Share by Manufacturers
3.2 Pentavalent Antimonials Revenue by Manufacturers
3.2.1 Pentavalent Antimonials Revenue by Manufacturers (2014-2019)
3.2.2 Pentavalent Antimonials Revenue Share by Manufacturers (2014-2019)
3.3 Pentavalent Antimonials Price by Manufacturers
3.4 Pentavalent Antimonials Manufacturing Base Distribution, Product Types
3.4.1 Pentavalent Antimonials Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pentavalent Antimonials Product Type
3.4.3 Date of International Manufacturers Enter into Pentavalent Antimonials Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Pentavalent Antimonials Sales by Type
4.2 Global Pentavalent Antimonials Revenue by Type
4.3 Pentavalent Antimonials Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Pentavalent Antimonials Breakdown Data by Application

6 North America
6.1 North America Pentavalent Antimonials by Country
6.1.1 North America Pentavalent Antimonials Sales by Country
6.1.2 North America Pentavalent Antimonials Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pentavalent Antimonials by Type
6.3 North America Pentavalent Antimonials by Application

7 Europe
7.1 Europe Pentavalent Antimonials by Country
7.1.1 Europe Pentavalent Antimonials Sales by Country
7.1.2 Europe Pentavalent Antimonials Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pentavalent Antimonials by Type
7.3 Europe Pentavalent Antimonials by Application

8 Asia Pacific
8.1 Asia Pacific Pentavalent Antimonials by Country
8.1.1 Asia Pacific Pentavalent Antimonials Sales by Country
8.1.2 Asia Pacific Pentavalent Antimonials Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pentavalent Antimonials by Type
8.3 Asia Pacific Pentavalent Antimonials by Application

9 Central & South America
9.1 Central & South America Pentavalent Antimonials by Country
9.1.1 Central & South America Pentavalent Antimonials Sales by Country
9.1.2 Central & South America Pentavalent Antimonials Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Pentavalent Antimonials by Type
9.3 Central & South America Pentavalent Antimonials by Application

10 Middle East and Africa
10.1 Middle East and Africa Pentavalent Antimonials by Country
10.1.1 Middle East and Africa Pentavalent Antimonials Sales by Country
10.1.2 Middle East and Africa Pentavalent Antimonials Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pentavalent Antimonials by Type
10.3 Middle East and Africa Pentavalent Antimonials by Application

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Pentavalent Antimonials Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi Pentavalent Antimonials Products Offered
11.1.5 Sanofi Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Pentavalent Antimonials Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Pentavalent Antimonials Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol-Myers Squibb Pentavalent Antimonials Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol-Myers Squibb Pentavalent Antimonials Products Offered
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Maiden Pharmaceuticals
11.4.1 Maiden Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Maiden Pharmaceuticals Pentavalent Antimonials Products Offered
11.4.5 Maiden Pharmaceuticals Recent Development
11.5 Xinhua Pharm
11.5.1 Xinhua Pharm Company Details
11.5.2 Company Business Overview
11.5.3 Xinhua Pharm Pentavalent Antimonials Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Xinhua Pharm Pentavalent Antimonials Products Offered
11.5.5 Xinhua Pharm Recent Development
11.6 Albert David
11.6.1 Albert David Company Details
11.6.2 Company Business Overview
11.6.3 Albert David Pentavalent Antimonials Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Albert David Pentavalent Antimonials Products Offered
11.6.5 Albert David Recent Development
11.7 Science Direct
11.7.1 Science Direct Company Details
11.7.2 Company Business Overview
11.7.3 Science Direct Pentavalent Antimonials Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Science Direct Pentavalent Antimonials Products Offered
11.7.5 Science Direct Recent Development

12 Future Forecast
12.1 Pentavalent Antimonials Market Forecast by Regions
12.1.1 Global Pentavalent Antimonials Sales Forecast by Regions 2019-2025
12.1.2 Global Pentavalent Antimonials Revenue Forecast by Regions 2019-2025
12.2 Pentavalent Antimonials Market Forecast by Type
12.2.1 Global Pentavalent Antimonials Sales Forecast by Type 2019-2025
12.2.2 Global Pentavalent Antimonials Revenue Forecast by Type 2019-2025
12.3 Pentavalent Antimonials Market Forecast by Application
12.4 North America Pentavalent Antimonials Forecast
12.5 Europe Pentavalent Antimonials Forecast
12.6 Asia Pacific Pentavalent Antimonials Forecast
12.7 Central & South America Pentavalent Antimonials Forecast
12.8 Middle East and Africa Pentavalent Antimonials Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pentavalent Antimonials Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer